EGb 761 has been shown to increase acetylcholine synthesis and release and increase cholinergic receptors leading to an increase in cholinergic neurotransmission. These effects may be observed in the neuromuscular system, manifested by changes in motoneuron pool excitability as measured by the Hoffmann reflex to motor response (H/M) ratio. 
Introduction

S
ince the development of a standardized Ginkgo biloba extract (EGb 761) in 1964, the majority of research has been focused on the extract's effect on the symptoms associated with impaired cognitive function (1, 2, 4, 9, 10, 12) . In the central nervous system (CNS), EGb 761 has been shown to increase acetylcholine (ACh) synthesis and release and increase cholinergic receptors leading to an increase in cholinergic neurotransmission (12) . Clinical evidence of these physiological changes has been seen acutely following EGb 761 administration in cognitively impaired subjects (2) . If EGb 761 does increase cholinergic signal transmission systemically, then its effects may also be observed in the neuromuscular system.
Increased production and release of ACh would lead to more ACh in the synaptic cleft, thereby decreasing neuronal threshold. An increased number of cholinergic receptors would further improve cholinergic transmission. Thus, a neural impulse that may not normally result in enough ACh release to sufficiently change postjunctional membrane potential to cause contraction would result in muscle contraction. This condition could be manifest as an increase in motoneuron pool excitability, which may be beneficial when applied to athletic performance and joint injury rehabilitation (5).
The Hoffmann reflex (H-reflex) is a neurophysiological response used to estimate motoneuron pool excitability. When type Ia afferents are stimulated with a low-intensity electrical stimulus, an impulse travels to the dorsal horn of the spinal cord and synapses with alpha-motoneurons (␣-MNs) eliciting an H-reflex that is recorded via electromyography (8, 11) . EGb 761 treatment may lower the resting potential allowing those ␣-MNs that may not have been recruited under normal conditions to be recruited increasing H-reflex amplitude.
The H-reflex is reported to represent the number of motor units that may be recruited, and the muscle response (M-response) elicited at higher stimulus intensity represents the total motoneuron pool. The Hreflex is most often reported as a ratio to the M-re- sponse for comparison purposes. In the human, these measurements are readily accessible in the soleus muscle by stimulation of the posterior tibial nerve in the popliteal fossa. Thus, the purpose of this study was to determine whether a single dose of Ginkgo biloba (EGb 761) would affect motoneuron pool excitability of the soleus muscle as measured by the maximum H-reflex to maximum M-response (H/M) ratio.
Methods
Experimental Approach to the Problem A 3 ϫ 4 factorial design was used in this study. The independent variables were group (control, placebo, and EGb 761) and time (pretest and 1, 2, and 3 hours posttreatment). The dependent variable was H/M ratio. Deberdt (2) observed an increase in cognitive function following the one-time administration of 160 mg Ginkgo biloba, suggesting that a single dose of Ginkgo biloba may induce a physiological effect. In humans, Ginkgo biloba activity levels peak between 1.5 and 3 hours postingestion (3). Increased cholinergic transmission could have an effect in the H-reflex pathway at the synapse between the Ia terminals and homonymous motoneuron pool. Based on the above information, a single dose of 180 mg Ginkgo biloba may express increased cholinergic transmission by means of increased H-reflex amplitude.
Subjects
Twenty (6 men, 14 women) healthy volunteers (height ϭ 167 Ϯ 8.2 cm; mass ϭ 64.7 Ϯ 7.6 kg; age ϭ 22.0 Ϯ 3.2 years) were recruited for this study. All participants completed a preparticipation questionnaire to assure that there were no contraindications for participation in the study. The institution's Human Subjects Committee approved the study, and informed consent was obtained from each subject prior to testing.
Testing Procedures
An electromyography (EMG) system (MP100, BIOPAC Systems Inc., Santa Barbara, CA) was used to collect H-reflex and M-response EMG data. Signals were amplified (DA100B, BIOPAC Systems Inc.) from disposable, pregelled Ag-AgCl electrodes. The sampling rate was set at 2,000 Hz, and each measurement was recorded for 60 milliseconds. After the area had been shaved, abraded, and cleaned, EMG electrodes were placed over the muscle belly of the medial soleus approximately 2 cm distal to the gastrocnemius. A ground electrode was placed on the medial malleolus.
To improve reliability in the H-reflex measurement (7), subjects lay supine with the involved leg supported at approximately 20Њ, the heel resting in a secure pad, and arms to their sides. Subjects listened to wave sounds from a CD through headphones while keeping their eyes fixed on a picture on the ceiling directly above them (6) . The H-reflex and M-response were elicited by applying a 1-millisecond percutaneous stimulus to the posterior tibial nerve in the popliteal fossa. Once isolated, the maximum H-reflex was measured 5 times at the same stimulus intensity with 20-second rest intervals. Maximum H-reflex amplitude for each trial was recorded. Following H-reflex measurements, the stimulus intensity was increased to elicit the M-response. When the maximum M-response was reached, 5 trials at the same stimulus intensity with 20-second rest intervals were obtained and recorded. This protocol for measuring the H-reflex and M-response has been shown to be reliable (ICC [3, 1] ϭ 0.932) (6) .
Following the pretest, subjects were randomly assigned to 1 of 3 groups. Subjects in the EGb 761 group received 180 mg EGb 761 (Nature's Way, Springville, UT) (2). The placebo group received a cellulose placebo and the control group received no treatment. The EGb 761 and placebo groups were double blinded.
Subjects remained in a supine position without removing surface EMG or stimulating electrodes from their original position. Subsequent H-reflex and M-response measurements were taken at 1, 2, and 3 hours posttreatment.
Statistical Analyses
Mean H/M ratio for each time period was calculated. A 3 ϫ 4 repeated-measures analysis of variance was used to compare treatment effects on H/M ratio over time. Sidak's t-test was used for post hoc testing as necessary. A significance level of p Յ 0.05 was set a priori for this study.
Results
H/M ratio by group over time are depicted in Figure  1 . No effect between treatments (F 2,19 ϭ 0.294, p ϭ 0.75) was observed. No differences were observed over time (F 3,19 ϭ 1.69, p ϭ 0.17). Likewise, no treatment by time interaction was noted (F 6,57 ϭ 1.31, p ϭ 0.27).
Discussion
EGb 761 increases ACh synthesis and release and cholinergic receptors increasing cholinergic signal transmission (12) . Heightened cholinergic signal transmission would lead to increased excitability of the motoneuron pool because of a decreased ␣-MN threshold. Increased excitability of the motoneuron pool is manifest by an increase in the H-reflex. Thus, the purpose of the present study was to determine whether a single dose of EGb 761 would affect motoneuron pool excitability of the soleus muscle. However, utilizing a dose of 180 mg EGb 761, no differences in H/M ratio among any of the 3 groups were observed.
Three possible reasons EGb 761 may not have been effective in increasing motoneuron pool recruitment in the present study are the time period that posttreatment H-reflex measurements were taken, the healthy subject population, and the EGb 761 dosing strategy. Half-life for Ginkgo biloba has been reported to be from 2 to 4 hours with activity levels peaking at 1.5-3 hours (3). In the present study, H-reflex measures were taken up to 3 hours posttreatment; however, to measure EGb 761 on the motoneuron pool, it may be necessary to continue measurements for a prolonged period.
Second, a single dose of 160 mg EGb 761 has been shown to increase memory in cognitively impaired subjects (2) . We chose a healthy subject population for the current investigation, which differs from Deberdt's pathological subjects. Further research using subjects with inhibition of the motoneuron pool such as seen with joint injury (5) may yield a different outcome because those with existing deficits may benefit from increased cholinergic signal transmission more so than healthy subjects.
Deberdt (2) observed positive results in memory with only 1 EGb 761 treatment, suggesting EGb 761 has an acute effect. The current findings indicate that increased ACh production and release and increased cholinergic receptors are not manifest systemically as an acute increase in motoneuron pool excitability. It is possible that an increased, prolonged dosing strategy such as that used in long-term studies of patients with Alzheimer's disease (9) and dementia (4) may be necessary to observe effects of improved cholinergic signal transmission on the motoneuron pool. In other words, for the significant enough changes in cholinergic transmission to occur, a time factor may be involved; thus, prolonged Ginkgo biloba supplementation may be able to induce that change.
Practical Applications
With the ever-increasing number of people consuming herbal and nutritional supplements, it is imperative that clinicians be aware of the various applications of a single compound. We present a novel possible use for a commonly consumed product. A single dose EGb 761 was not effective in increasing motoneuron pool excitability and cannot presently be considered as a performance enhancer or therapeutic intervention. However, sound scientific reasoning supports the notion that with the different testing and/or dosing strategies EGb 761 may be shown efficacious. EGb 761 remains a viable possibility as an adjunct therapy for increasing performance and assisting in the rehabilitation of musculoskeletal injuries. Future research should focus on a prolonged, increased dose of EGb 761 and appropriate timing of reflex testing.
